Denali Therapeutics
DNLI
DNLI
198 hedge funds and large institutions have $2.93B invested in Denali Therapeutics in 2022 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 52 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 199 → 198 (-1)
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
Holders
198
Holding in Top 10
3
Calls
$1.93M
Puts
$270K
Top Buyers
| 1 | +$142M | |
| 2 | +$60.4M | |
| 3 | +$43M | |
| 4 |
Temasek Holdings
Singapore
|
+$26.1M |
| 5 |
DM
Deerfield Management
New York
|
+$22.2M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$13.6M | |
| 3 | -$8.34M | |
| 4 |
Morgan Stanley
New York
|
-$6.92M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.64M |